Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Corneal dystrophy-perceptive deafness (CDPD) or Harboyan syndrome is a degenerative corneal disorder characterized by the association of congenital hereditary endothelial dystrophy (CHED) with progressive, postlingual sensorineural hearing loss.
Features include very common findings: Inner ear hearing loss (sensorineural hearing impairment), Clouding of the cornea (corneal dystrophy), Visual impairment, and Cloudy or opaque cornea (corneal opacity); and common findings: Nystagmus. 7 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 5 | Opacification of the corneal stroma, Clouding of the cornea (corneal dystrophy), Visual impairment |
SLC4A11 function has not been fully characterized.
Corneal dystrophy-perceptive deafness syndrome is associated with mutations in the SLC4A11 gene on chromosome 20.
Genetic testing for SLC4A11 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 4 very common features, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for corneal dystrophy-perceptive deafness syndrome.
11 publications have been identified in PubMed for corneal dystrophy-perceptive deafness syndrome. Research spans Review / Meta-Analysis (56%), Case Report / Case Series (33%), and Gene Therapy / Novel Therapeutics (11%).
Kirwin DA (2026). [PMID: 41854963](https://pubmed.ncbi.nlm.nih.gov/41854963/). *J Assoc Res Otolaryngol*. [Review / Meta-Analysis]
Li H (2026). [PMID: 41897284](https://pubmed.ncbi.nlm.nih.gov/41897284/). *Biomolecules*. [Review / Meta-Analysis]
Kovaleva PA (2025). [PMID: 40563515](https://pubmed.ncbi.nlm.nih.gov/40563515/). *Biomolecules*. [Review / Meta-Analysis]
Gagliardi M (2025). [PMID: 39927073](https://pubmed.ncbi.nlm.nih.gov/39927073/). *American journal of ophthalmology case reports*. [Case Report / Case Series]
Arnaud L (2025). [PMID: 39455380](https://pubmed.ncbi.nlm.nih.gov/39455380/). *La Revue de medecine interne*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 11:56 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
Li X (2025). [PMID: 40731416](https://pubmed.ncbi.nlm.nih.gov/40731416/). *Journal of ovarian research*. [Gene Therapy / Novel Therapeutics]
Estévez-Domínguez R (2025). [PMID: 40721026](https://pubmed.ncbi.nlm.nih.gov/40721026/). *Archivos de la Sociedad Espanola de Oftalmologia*. [Case Report / Case Series]
Karataş E (2024). [PMID: 39319907](https://pubmed.ncbi.nlm.nih.gov/39319907/). *Arquivos brasileiros de oftalmologia*. [Case Report / Case Series]
Krishnamurthy R (2024). [PMID: 39278530](https://pubmed.ncbi.nlm.nih.gov/39278530/). *Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus*. [Review / Meta-Analysis]